Long acting aripiprazole influences cognitive functions in recent onset schizophrenia.

Rationale: Beneficial effects of aripiprazole on cognition in schizophrenia have been previously reported, but not in recent onset schizophrenia. Cognitive impairments have also been associated with catechol-O-methyltransferase (COMT), methylenetetrahydrofolate reductase (MTHFR), and serotonin trans...

Descripción completa

Detalles Bibliográficos
Publicado en:Psychopharmacology Vol. 238; no. 6; pp. 1563 - 1574
Autores principales: Peitl, Vjekoslav, Štefanović, Mario, Orlović, Ivona, Culej, Jelena, Rendulić, Ana, Matešić, Krunoslav, Karlović, Dalibor
Formato: Journal Article
Publicado: Springer Nature Jun2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=150429676&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 150429676
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00333158
        EJD
      jtl: Psychopharmacology
      issn: 00333158
      maglogo: N
    pubinfo:
      dt: Jun2021
      vid: 238
      iid: 6
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        150429676
        148673019
        10.1007/s00213-021-05788-w
        150429676
      ppf: 1563
      ppct: 11
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Long acting aripiprazole influences cognitive functions in recent onset schizophrenia.
      aug:
        au:
          Peitl, Vjekoslav
          Štefanović, Mario
          Orlović, Ivona
          Culej, Jelena
          Rendulić, Ana
          Matešić, Krunoslav
          Karlović, Dalibor
        affil: Department of Psychiatry, University Hospital Centre Sestre Milosrdnice, Zagreb, Croatia
      sug:
      ab: Rationale: Beneficial effects of aripiprazole on cognition in schizophrenia have been previously reported, but not in recent onset schizophrenia. Cognitive impairments have also been associated with catechol-O-methyltransferase (COMT), methylenetetrahydrofolate reductase (MTHFR), and serotonin transporter (SERT) gene polymorphisms which were earlier implicated in the pathophysiology of schizophrenia. Objectives: This study examined the short-term influence of aripiprazole long-acting injectable (LAI) as well as of COMT, MTHFR, and SERT gene polymorphisms and their interactions on clinical features and cognitive functions in inpatients with recent onset schizophrenia. Methods: This study included 98 inpatients suffering from recent onset schizophrenia diagnosed according to DSM-5 criteria. Three months after initiating aripiprazole LAI, the severity of symptoms was assessed by the Positive and Negative Syndrome Scale (PANSS), while cognitive functions were measured by 5-KOG test for cognition. Genotypes of SERT, MTHFR, and COMT gene were determined by different polymerase chain reaction (PCR) methods. Results: Three-month aripiprazole LAI treatment was associated with a statistically significant change of PANSS total (p<0.001) and subscale scores as well as cognitive parameters of delayed recall (p<0.03), attention (p<0.01), and executive functions in the form of less perseverations (p<0.03), without influencing other examined cognitive functions. However, it significantly influenced composite cognitive score (p<0.02). In regard to the investigated genetic polymorphisms, we established a positive association between the COMT polymorphism (M/M allele carriers) and attention (p<0.01). Additionally, we also established a positive association between the COMT – MTHFR interaction and attention (p<0.02), as well as perseveration item belonging to executive functions (p<0.01). Two other investigated polymorphisms (MTHFR and SERT) were not significantly associated with cognitive indices. Investigated genetic polymorphisms and their interactions were not associated with PANSS scores. Conclusions: Our findings suggest that aripiprazole LAI improves individual cognitive functions in recent onset schizophrenia. Investigated COMT polymorphism (Met/Met genotype), as well as the COMT-MTHFR interaction, were positively associated with attention and executive functioning (perseveration), potentially implying COMT's biomarker potential in terms of cognition in schizophrenia.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N